BIOMARKERIQ
LIVE

Serial Number

99716392

Owner

euVita Health, Inc.

Attorney

Reese Serra

Filing Date

Mar 21, 2026

Add to watchlist:

No watchlists yet
View on USPTO

BIOMARKERIQ Trademark

Serial Number: 99716392

BIOMARKERIQ is a trademark filed by euVita Health, Inc. on March 21, 2026. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

euVita Health, Inc. (5 trademarks)

400 North Flagler Drive
West Palm Beach, FL 33401

Entity Type: 03

Trademark Details

Filing Date

March 21, 2026

Registration Date

Not Registered

Published for Opposition

September 8, 2026

Goods & Services

Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for creating complex data science analyses; Providing a website featuring non-downloadable software using artificial intelligence (AI) for creating sci-ai biomarker analysis reports used to develop treatment plans; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for creating sci-ai biomarker analysis reports used to develop treatment plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for creating sci-ai biomarker analysis reports used to develop treatment plans; Software as a service (SAAS) services featuring software for analyzing and reporting self-assessment of illness for the purpose of treatment plans contact tracing

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 2, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 10, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Aug 10, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 10, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 10, 2026 CNEA
ASSIGNED TO EXAMINER
Aug 3, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 21, 2026 MAFR
NEW APPLICATION ENTERED
Mar 21, 2026 NWAP